Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1007/s12012-021-09674-x

http://scihub22266oqcxt.onion/10.1007/s12012-021-09674-x
suck pdf from google scholar
34255300!8275916!34255300
unlimited free pdf from europmc34255300    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid34255300      Cardiovasc+Toxicol 2021 ; 21 (10): 781-789
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Plausible Positive Effects of Statins in COVID-19 Patient #MMPMID34255300
  • Vitiello A; Ferrara F
  • Cardiovasc Toxicol 2021[Oct]; 21 (10): 781-789 PMID34255300show ga
  • Since the onset of the global COVID-19 pandemic, there has been much discussion about the advantages and disadvantages of ongoing chronic drug therapies in SARS-CoV-2-positive patients. These discussions include also statins treatment. The statins are among the most widely used drugs in the global population. Statins aim to lower cholesterol, which is essential for many biological processes but can lead to heart disease if levels are too high; however, also the pleiotropic effects of statins are well known. So could the anti-inflammatory or the potential antiviral effects of statins be helpful in avoiding extreme inflammation and severity in COVID-19? To date, there are conflicting opinions on the effects of statins in the course of COVID-19 infection. The aim of this article is to describe the molecular and pharmacological basis of the pleiotropic effects of statins that could be more involved in the fight against COVID-19 infection and to investigate the current epidemiological evidence in the literature on the current and important topic.
  • |*COVID-19 Drug Treatment[MESH]
  • |Animals[MESH]
  • |Anti-Inflammatory Agents/adverse effects/*therapeutic use[MESH]
  • |Antiviral Agents/adverse effects/*therapeutic use[MESH]
  • |COVID-19/epidemiology/physiopathology/virology[MESH]
  • |Heart Diseases/*drug therapy/epidemiology/physiopathology/virology[MESH]
  • |Heart/*drug effects/physiopathology/virology[MESH]
  • |Host-Pathogen Interactions[MESH]
  • |Humans[MESH]
  • |Hydroxymethylglutaryl-CoA Reductase Inhibitors/adverse effects/*therapeutic use[MESH]
  • |SARS-CoV-2/*drug effects/pathogenicity[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box